Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Specimen Handling 111Magnetic Resonance Spectroscopy 77Biopsy 76pembrolizumab 61Cyclophosphamide 51fludarabine 42Carboplatin 26Cisplatin 23Cetuximab 23Nivolumab 22Radiotherapy 21Bevacizumab 21venetoclax 20atezolizumab 18X-Rays 18fludarabine phosphate 17Radiation 17Fluorouracil 17Ipilimumab 16Gemcitabine 16Paclitaxel 15Leucovorin 15Cytarabine 15Temozolomide 14Pemetrexed 14Irinotecan 14durvalumab 13Oxaliplatin 13CTLA-4 Antigen 12Azacitidine 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × human papillomavirus vaccine, TA × 30 days × Clear all
NCT06315257 2026-05-20

A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Recruiting
32 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡